Bcl-3 is an inhibitor of transcription factor NF-κB (IκB) family protein that associates with DNA-bound homodimers of the NF-κB subunits p50 and p52 and can either promote NF-κB-dependent gene expression or inhibit it. In Immunity, Siebenlist and colleagues show that Bcl-3 serves as a regulator of the TH1 lineage identity by preventing conversion into TH17 cells. In a model of colitis in mice deficient in recombination-activating gene 1 (Rag1−/− mice), transferred Bcl3−/− CD4+T cells do not induce inflammation. Naive Bcl3−/− CD4+ T cells differentiate normally into TH1 cells in vitro and in vivo, but trace experiments with interferon-γ (IFN-γ) tagged with yellow fluorescent protein show that they gradually and cell-autonomously convert into IFN-γ+IL-17+ T cells and later into IL-17+ T cells in the mesenteric lymph nodes of Rag1−/− hosts after transfer. The process is dependent on microbiota, stimulation via the T cell antigen receptor and IL-23. In TH1 cells, Bcl-3 associates with the NF-κB subunits c-Rel and p50 in the promoter of the gene encoding the transcription factor RORγt. Expression of RORγt is higher in Bcl-3-deficient TH1 cells, which is sufficient to induce conversion into TH17 cells.
Rights and permissions
About this article
Cite this article
Visan, I. TH1 identity. Nat Immunol 15, 1103 (2014). https://doi.org/10.1038/ni.3041
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3041